Factors affecting graft survival among patients receiving kidneys from live donors: A single-center experience

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ghoneim, Mohamed A ^a   Bakr, Mohamed A ^a   Refaie, Ayman F ^a   Akl, Ahmed I ^a   Shokeir, Ahmed A ^a   Shehab El Dein, Ahmed B ^a   Ammar, Hesham M ^a   Ismail, Amani M ^a   Sheashaa, Hussein A ^a   El Baz, Mahmoud A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DIURESIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; RENOVASCULAR HYPERTENSION; AGED; CLINICAL TRIAL; COMORBIDITY; EGYPT; EPIDEMIOLOGY; GRAFT REJECTION; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; CHRONIC KIDNEY FAILURE; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; EGYPT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880180331     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/912413     Document Type: Article

References (32)

1. Ghoneim M. A., Sobh M. A., Shokeir A. A., Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation. American Journal of Nephrology 1993 13 6 437 441 2-s2.0-0027772328
2. Ghoneim M. A., Sobh M. A., Shokeir A. A., Bakr M. A., El-Sherif A., Foda M. A., Prospective randomized study of triple Vs conventional immunosuppression in living-donor kidney transplantation. Transplantation Proceedings 1993 25 3 2243 2245 2-s2.0-0027266969
3. Nematalla A. H., Bakr M. A., Gheith O. A., Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized controlled study. Experimental and Clinical Transplantation 2007 5 2 673 679 2-s2.0-38549125050
4. Hamdy A. F., Bakr M. A., Ghoneim M. A., Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients. Journal of the American Society of Nephrology 2008 19 6 1225 1232 2-s2.0-48049104898 10.1681/ASN.2007091001
5. Tuttle-Newhall J. E., Krishnan S. M., Levy M. F., Organ donation and utilization in the United States: 1998-2007. American Journal of Transplantation 2009 9 4, part 2 879 893 2-s2.0-63449125341 10.1111/j.1600-6143.2009.02565.x
6. DSO report on organ donation and transplantation in Germany 2000, pp. 45-46
7. Lee S., Kim J., Shin M., Kim E., Moon J., Jung G., Choi G., Kwon C., Joh J., Lee S., Kim S., Comparison of outcomes of living and deceased donor kidney grafts surviving longer than 5 years in Korea. Transplantation Proceedings 2010 42 3 775 777 2-s2.0-77955485581
8. Roodnat J. I., van Riemsdijk I. C., Mulder P. G. H., Doxiadis I., Claas F. H. J., Ijzermans J. N. M., van Gelder T., Weimar W., The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation 2003 75 12 2014 2018 2-s2.0-0037774802
9. Fuggle S. V., Allen J. E., Johnson R. J., Collett D., Mason P. D., Dudley C., Rudge C. J., Bradley J. A., Watson C. J. E., Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation 2010 89 6 694 701 2-s2.0-77950100299 10.1097/TP.0b013e3181c7dc99
10. Lowell J. A., Brennan D. C., Shenoy S., Hagerty D., Miller S., Ceriotti C., Cole B., Howard T. K., Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: a 12-year single-center experience. Surgery 1996 119 5 538 543 2-s2.0-0030001691 10.1016/S0039-6060(96)80264-9
11. Futagawa Y., Waki K., Gjertson D. W., Terasaki P. I., Living-unrelated donors yield higher graft survival rates than parental donors. Transplantation 2005 79 9 1169 1174 2-s2.0-18644370434 10.1097/01.TP.0000160763.60597.D0
12. El-Mekresh M., Osman Y., Ali-El-Dein B., El-Diasty T., Ghoneim M. A., Urological complications after living-donor renal transplantation. BJU International 2001 87 4 295 306 2-s2.0-0035068506 10.1046/j.1464-410x.2001. 00113.x
13. Issa N., Stephany B., Fatica R., Nurko S., Krishnamurthi V., Goldfarb D. A., Braun W. E., Dennis V. W., Heeger P. S., Poggio E. D., Donor factors influencing graft outcomes in live donor kidney transplantation. Transplantation 2007 83 5 593 599 2-s2.0-33947330443 10.1097/01.tp.0000256284.78721.ba
14. Noppakun K., Cosio F. G., Dean P. G., Taler S. J., Wauters R., Grande J. P., Living donor age and kidney transplant outcomes. American Journal of Transplantation 2011 11 6 1279 1286 2-s2.0-79958810259 10.1111/j.1600-6143.2011. 03552.x
15. Peña De La Vega L. S., Torres A., Bohorquez H. E., Heimbach J. K., Gloor J. M., Schwab T. R., Taler S. J., Nyberg S. L., Ishitani M. B., Prieto M., Velosa J. A., Larson T. S., Stegall M. D., Cosio F. G., Textor S. C., Griffin M. D., Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney International 2004 66 4 1654 1661 2-s2.0-4644313399 10.1111/j.1523-1755.2004.00932.x
16. Ghoneim M. A., Bakr M. A., Hassan N., Wahba I., Fouda A. S., Sobh M. A., Shehab El-Dein A. B., Shokeir A. A., El-Mekresh M. M., Ali-El-Dein B., Osman Y. M., Moustafa A., El-Chenawi F., Live-donor renal transplantation at the Urology & Nephrology Center of Mansoura: 1976-1998. Clinical Transplants 2001 167 178 2-s2.0-19244372999
17. Collaborative Transplant Study, University of Heidelberg, Germany, January 2012, http://www.ctstransplant.org
18. Weimer R., Deisz S., Dietrich H., Renner F., Bödeker R.-H., Daniel V., Kamali-Ernst S., Ernst W., Padberg W., Opelz G., Impact of maintenance immunosuppressive regimens-balance between graft protective suppression of immune functions and a near physiological immune response. Transplant International 2011 24 6 596 609 2-s2.0-79955558933 10.1111/j.1432-2277.2011. 01241.x
19. Nashan B., Moore R., Amlot P., Schmidt A. G., Abeywickrama K., Soulillou J. P., Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. The Lancet 1997 350 9086 1193 1198 2-s2.0-0031586439
20. Keown P. A., Balshaw R., Khorasheh S., Chong M., Marra C., Kalo Z., Korn A., Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation. BioDrugs 2003 17 4 271 279 2-s2.0-0041733081 10.2165/00063030-200317040-00006
21. Sheashaa H. A., Bakr M. A., Rashad R. H., Ismail A. M., Sobh M. A., Ghoneim M. A., Ten-year follow-up of basiliximab induction therapy for live-donor kidney transplant: a prospective randomized controlled study. Experimental and Clinical Transplantation 2011 9 4 247 251 2-s2.0-84860395294
22. Lemieux I., Houde I., Pascot A., Lachance J.-G., Noël R., Radeau T., Després J.-P., Bergeron J., Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney International 2002 62 5 1839 1847 2-s2.0-0036408206 10.1046/j.1523-1755.2002. 00611.x
23. Opelz G., Döhler B., Laux G., Collaborative Transplant Study, Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. American Journal of Transplantation 2005 5 4 I 720 728 2-s2.0-16244380792 10.1111/j.1600-6143.2004.00765.x
24. Woodle E. S., First M. R., Pirsch J., Shihab F., Gaber A. O., van Veldhuisen P., Astellas Corticosteroid Withdrawal Study Group, A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Annals of Surgery 2008 248 4 564 577 2-s2.0-55449124588 10.1097/SLA.0b013e318187d1da
25. Lightner A., Concepcion W., Grimm P., Steroid avoidance in renal transplantation. Current Opinion in Organ Transplantation 2011 16 5 477 482 2-s2.0-80052658469 10.1097/MOT.0b013e32834a8c74
26. Pascual J., Steroid avoidance or withdrawal in kidney transplantation. Current Opinion in Organ Transplantation 2011 16 6 600 605 2-s2.0-81255185330 10.1097/MOT.0b013e32834c23fa
27. Knight S. R., Morris P. J., Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010 89 1 1 14 2-s2.0-74549170957 10.1097/TP.0b013e3181c518cc
28. Remuzzi G., Perico N., Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney International 1995 52 S70 S74 2-s2.0-0028868941
29. Myers B. D., Newton L., Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. Journal of the American Society of Nephrology 1991 2, supplement 1 S45 S52 2-s2.0-0026212083
30. Nankivell B. J., Borrows R. J., Fung C. L., O'Connell P. J., Allen R. D. M., Chapman J. R., The natural history of chronic allograft nephropathy. The New England Journal of Medicine 2003 349 24 2326 2333 2-s2.0-0344666767 10.1056/NEJMoa020009
31. Refaie A. F., Mahmoud K. M., Ismail A. M., Sheashaa H. A., Kamal A. I., Ghoneim M. A., Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant. Experimental and Clinical Transplantation 2011 9 5 295 301 2-s2.0-80053966793
32. Donia A. F., Mostafa A., Refaie H., El-Baz M., Kamal M. M., Ghoneim M. A., Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience. Transplantation 2008 86 8 1139 1142 2-s2.0-55949125868 10.1097/TP.0b013e318187ccb3